TCF
Kite Pharma, Inc.
Mark For: TCF® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79152345 |
| Registration Number | 4903231 |
| Mark Literal Elements | TCF |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2016-02-23 |
| Basis | 66(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | Yes |
| Current Basis | No |
| No Basis | No |
| Attorney Docket Number | 206113.60383 |
| Law Office Assigned | L70 |
| Employee Name | ALTREE, NICHOLAS |
Timeline
| 2014-06-13 | Application Filed |
| 2015-12-08 | Published |
| 2015-12-08 | Published for Opposition |
| 2016-02-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-02-23 | Status: Live/Registered |
| 2016-02-23 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2016-02-23 | Trademark Registered |
| 2018-07-08 | Transaction Date |
| 2022-08-23 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  Kite Pharma, Inc. |
| Address | 2400 Broadway Santa Monica CA 90404 UNITED STATES |
| Legal Entity Type | Limited Liability Corporation |
| Legal Entity State | No Place Where Organized Found |
| Party: | Kite Pharma EU B.V. |
| Address | Science Park 408 XH Amsterdam NL NL-1098 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | NL |
*multiple parties listed, check assignment documents for ownership information
Documents
ApplicationAttorney of Record
Good, Services, and Codes
IC 001. US 001 005 006 010 026 046. G & S: chemical preparations for industrial and scientific use, namely, polypeptides and proteins made by genetic engineering, including fusion proteins as well as nucleic acids encoding these polypeptides and proteins, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of fusion proteins, fusion peptides and cells, namely, body cells and cells of the immune system of mammals, including human cells; diagnostic preparations except for medical purposes
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical and veterinary preparations for the treatment of cancer, including hematologic cancers, viral mediated diseases, bacterial mediated diseases, and inflammatory and autoimmune diseases, including rheumatoid arthritis, osteoarthritis, Crohn's disease, psoriasis, psoriatic arthritis, namely, polypeptides and proteins made by genetic engineering, including fusion proteins, cells, namely, body cells and cells of the immune system of mammals, including human cells; diagnostic preparations for medical purposes
IC 042. US 100 101. G & S: Scientific and industrial research in the field of biochemistry, diagnostics and pharmaceutics; biochemical or pharmaceutical laboratory services, namely, synthesis of recombinant polypeptides and proteins, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | chemical preparations for industrial and scientific use, namely, polypeptides and proteins made by genetic engineering, including fusion proteins as well as nucleic acids encoding these polypeptides and proteins, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of fusion proteins, fusion peptides and cells, namely, body cells and cells of the immune system of mammals, including human cells; diagnostic preparations except for medical purposes |
Assignments
| Description | Date |
|---|---|
 Trademark Assignment 7625-0867 [2 Pages] | 2022-02-17 |
| Trademark Assignment 5587-0148 [2 Pages] | 2015-07-30 |
| Trademark Assignment 5538-0669 [2 Pages] | 2015-05-14 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| CHANGE OF OWNER RECEIVED FROM IB | 2022-02-18 | |
| TEAS SECTION 71 & 15 RECEIVED | 2022-02-15 | |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-12-04 | |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-04-19 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-04-19 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-04-19 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-04-19 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-04-19 | 88888 |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2021-02-23 | |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2016-07-15 | |
| FINAL DISPOSITION PROCESSED | 2016-05-25 | 68359 |
| FINAL DISPOSITION NOTICE SENT TO IB | 2016-05-25 | |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2016-05-23 | |
| REGISTERED-PRINCIPAL REGISTER | 2016-02-23 | |
| PUBLISHED FOR OPPOSITION | 2015-12-08 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-12-08 | |
| NOTIFICATION PROCESSED BY IB | 2015-12-04 | |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2015-11-18 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-11-18 | |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2015-11-18 | |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-11-02 | 69712 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-10-21 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-10-17 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-10-16 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-10-16 | 88889 |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2015-07-30 | |
| CHANGE OF OWNER RECEIVED FROM IB | 2015-05-14 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2015-04-16 | 6325 |
| NON-FINAL ACTION WRITTEN | 2015-04-16 | 73699 |
| NON-FINAL ACTION E-MAILED | 2015-04-16 | 6325 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-04-09 | 69712 |
| ASSIGNED TO LIE | 2015-04-09 | 69712 |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2015-04-09 | 69712 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-04-06 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-04-06 | 69712 |
| REFUSAL PROCESSED BY IB | 2014-10-24 | |
| REFUSAL PROCESSED BY MPU | 2014-10-08 | 72629 |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2014-10-08 | |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2014-10-08 | |
| NON-FINAL ACTION WRITTEN | 2014-10-07 | 73699 |
| APPLICATION FILING RECEIPT MAILED | 2014-10-04 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-09-30 | |
| ASSIGNED TO EXAMINER | 2014-09-30 | 73699 |
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2014-09-25 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 